Education
About Us
Working with TipRanks
Follow Us
Korro Bio (KRRO)
NASDAQ:KRRO
Total Valuation
Korro Bio has a market cap or net worth of $149.31M. The enterprise value is $99.92M.
Market Cap$149.31M
Enterprise Value$99.92M
Share Statistics
Korro Bio has 9,390,492 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,390,492
Owned by Insiders31.95%
Owned by Institutions0.02%
Financial Efficiency
Korro Bio’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -43.31%.
Return on Equity (ROE)-0.52
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-43.31%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee20.28K
Profits Per Employee-746.26K
Employee Count112
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio0.85
Price to Fair Value2.12
Price to FCF-1.57
Price to Operating Cash Flow-1.89
PEG Ratio2.53
Income Statement
In the last 12 months, Korro Bio had revenue of 2.27M and earned -83.58M in profits. Earnings per share was -9.37.
Revenue2.27M
Gross Profit2.27M
Operating Income-91.91M
Pretax Income-83.44M
Net Income-83.58M
EBITDA-88.34M
Earnings Per Share (EPS)-9.37
Cash Flow
In the last 12 months, operating cash flow was -62.63M and capital expenditures -12.41M, giving a free cash flow of -75.05M billion.
Operating Cash Flow-62.63M
Free Cash Flow-75.05M
Free Cash Flow per Share-7.99
Dividends & Yields
Korro Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.78
52-Week Price Change-69.70%
50-Day Moving Average13.49
200-Day Moving Average30.48
Relative Strength Index (RSI)60.73
Average Volume (3m)110.39K
Important Dates
Korro Bio upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Korro Bio as a current ratio of 8.79, with Debt / Equity ratio of 32.52%
Current Ratio8.79
Quick Ratio8.79
Debt to Market Cap<0.01
Net Debt to EBITDA0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Korro Bio has paid 141.00K in taxes.
Income Tax141.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Korro Bio EV to EBITDA ratio is -3.72, with an EV/FCF ratio of -4.22.
EV to Sales144.75
EV to EBITDA-3.72
EV to Free Cash Flow-4.22
EV to Operating Cash Flow-5.47
Balance Sheet
Korro Bio has $114.95M in cash and marketable securities with $45.19M in debt, giving a net cash position of -$69.77M billion.
Cash & Marketable Securities$114.95M
Total Debt$45.19M
Net Cash-$69.77M
Net Cash Per Share-$7.43
Tangible Book Value Per Share$17.98
Margins
Gross margin is 100.00%, with operating margin of -4047.12%, and net profit margin of -3680.36%.
Gross Margin100.00%
Operating Margin-4047.12%
Pretax Margin-3674.15%
Net Profit Margin-3680.36%
EBITDA Margin-3890.14%
EBIT Margin-4047.12%
Analyst Forecast
The average price target for Korro Bio is $103.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$103.80
Price Target Upside552.83% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast85.19%